{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:35:22Z","timestamp":1787726122932,"version":"build-2784847793"},"reference-count":83,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872923"],"award-info":[{"award-number":["81872923"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.apsb.2022.10.006","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T06:48:18Z","timestamp":1665557298000},"page":"1110-1127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0614-3948","authenticated-orcid":false,"given":"Mengyao","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0206-1889","authenticated-orcid":false,"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0731-6967","authenticated-orcid":false,"given":"Ming","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1696-6208","authenticated-orcid":false,"given":"Fangfang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2806-6883","authenticated-orcid":false,"given":"Liping","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3478-1610","authenticated-orcid":false,"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2022.10.006_bib1","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1038\/s41467-020-18047-x","article-title":"Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGF\u03b2 signaling through TGFBR1 stabilization","volume":"11","author":"Lee","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2022.10.006_bib2","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.apsb.2022.10.006_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-pathol-012513-104706","article-title":"Pathogenesis of idiopathic pulmonary fibrosis","volume":"9","author":"Wolters","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.apsb.2022.10.006_bib4","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00018-020-03693-7","article-title":"Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis","volume":"78","author":"Phan","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2022.10.006_bib5","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2022.10.006_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0021-2019","article-title":"The therapy of idiopathic pulmonary fibrosis: what is next?.","volume":"28","author":"Somogyi","year":"2019","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.apsb.2022.10.006_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109485","article-title":"Endothelial tight junctions and their regulatory signaling pathways in vascular homeostasis and disease","volume":"66","author":"Cong","year":"2020","journal-title":"Cell Signal"},{"key":"10.1016\/j.apsb.2022.10.006_bib8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1083\/jcb.201404140","article-title":"ZO-1 controls endothelial adherens junctions, cell\u2013cell tension, angiogenesis, and barrier formation","volume":"208","author":"Tornavaca","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2022.10.006_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature17040","article-title":"Angiocrine functions of organ-specific endothelial cells","volume":"529","author":"Rafii","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2022.10.006_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccell.2017.01.007","article-title":"Endothelial Notch1 activity facilitates metastasis","volume":"31","author":"Wieland","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2022.10.006_bib11","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1152\/physrev.00037.2018","article-title":"Passing the vascular barrier: endothelial signaling processes controlling extravasation","volume":"99","author":"Wettschureck","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2022.10.006_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature04479","article-title":"Endothelial cells and VEGF in vascular development","volume":"438","author":"Coultas","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2022.10.006_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1152\/physrev.00012.2005","article-title":"Signaling mechanisms regulating endothelial permeability","volume":"86","author":"Mehta","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2022.10.006_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101638","article-title":"Targeting NOX4 alleviates sepsis-induced acute lung injury via attenuation of redox-sensitive activation of CaMKII\/ERK1\/2\/MLCK and endothelial cell barrier dysfunction","volume":"36","author":"Jiang","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2022.10.006_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2022.10.006_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1042\/bj3490385","article-title":"Sphingosine 1-phosphate signalling in mammalian cells","volume":"349","author":"Pyne","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.apsb.2022.10.006_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/thoraxjnl-2011-200026","article-title":"Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition","volume":"67","author":"Milara","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.apsb.2022.10.006_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2017.11.001","article-title":"The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: recent findings and new perspectives","volume":"185","author":"Huwiler","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2022.10.006_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40263-015-0261-z","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis","volume":"29","author":"Subei","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.apsb.2022.10.006_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2022.10.006_bib21","first-page":"1871","article-title":"Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice","volume":"119","author":"Camerer","year":"2009","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2022.10.006_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00441-016-2545-0","article-title":"Development of the lung","volume":"367","author":"Schittny","year":"2017","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.apsb.2022.10.006_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41586-020-2822-7","article-title":"Capillary cell-type specialization in the alveolus","volume":"586","author":"Gillich","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2022.10.006_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1165\/rcmb.2012-0411TR","article-title":"Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury","volume":"49","author":"Natarajan","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.apsb.2022.10.006_bib25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1164\/rccm.200309-1258OC","article-title":"Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury","volume":"169","author":"Peng","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.apsb.2022.10.006_bib26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/rccm.200405-684OC","article-title":"Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury","volume":"170","author":"McVerry","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.apsb.2022.10.006_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jbior.2014.09.008","article-title":"Sphingolipids in pulmonary fibrosis","volume":"57","author":"Huang","year":"2015","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.apsb.2022.10.006_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1165\/rcmb.2020-0408OC","article-title":"Endothelial-specific loss of sphingosine-1-phosphate receptor 1 increases vascular permeability and exacerbates bleomycin-induced pulmonary fibrosis","volume":"66","author":"Knipe","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.apsb.2022.10.006_bib29","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1165\/rcmb.2009-0345OC","article-title":"Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury","volume":"43","author":"Shea","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.apsb.2022.10.006_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2014.07.081","article-title":"Discovery of oxazole and triazole derivatives as potent and selective S1P1 agonists through pharmacophore-guided design","volume":"85","author":"Tian","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2022.10.006_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1972","article-title":"Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis","volume":"6","author":"Habermann","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2022.10.006_bib32","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00117-2019","article-title":"RNA sequencing of transplant-stage idiopathic pulmonary fibrosis lung reveals unique pathway regulation","volume":"5","author":"Sivakumar","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.apsb.2022.10.006_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41586-018-0590-4","article-title":"Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris","volume":"562","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2022.10.006_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCRESAHA.120.318412","article-title":"Programming to S1PR1+ endothelial cells promotes restoration of vascular integrity","volume":"129","author":"Akhter","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2022.10.006_bib35","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1593\/neo.12942","article-title":"Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases","volume":"14","author":"Shang","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.apsb.2022.10.006_bib36","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1165\/rcmb.2013-0456OC","article-title":"Claudin-18 deficiency results in alveolar barrier dysfunction and impaired alveologenesis in mice","volume":"51","author":"LaFemina","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.apsb.2022.10.006_bib37","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbamem.2007.07.012","article-title":"Adherens and tight junctions: structure, function and connections to the actin cytoskeleton","volume":"1778","author":"Hartsock","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2022.10.006_bib38","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/CIRCRESAHA.119.315428","article-title":"T-cell-derived miRNA-214 mediates perivascular fibrosis in hypertension","volume":"126","author":"Nosalski","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2022.10.006_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9284","article-title":"Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis","volume":"11","author":"Yang","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2022.10.006_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50718-8","article-title":"The role of extracellular matrix in mouse and human corneal neovascularization","volume":"9","author":"Barbariga","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2022.10.006_bib41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0945-053X(00)00074-3","article-title":"The EMILIN protein family","volume":"19","author":"Colombatti","year":"2000","journal-title":"Matrix Biol"},{"key":"10.1016\/j.apsb.2022.10.006_bib42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.apsb.2022.10.006_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50055-w","article-title":"ECM alterations in Fndc3a (fibronectin domain containing protein 3A) deficient zebrafish cause temporal fin development and regeneration defects","volume":"9","author":"Liedtke","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2022.10.006_bib44","first-page":"4396","article-title":"CFTR interacts with ZO-1 to regulate tight junction assembly and epithelial differentiation through the ZONAB pathway","volume":"127","author":"Ruan","year":"2014","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2022.10.006_bib45","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1165\/rcmb.2015-0071OC","article-title":"Glucocorticoids regulate tight junction permeability of lung epithelia by modulating claudin 8","volume":"54","author":"Kielgast","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.apsb.2022.10.006_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40265-020-01431-8","article-title":"Sphingosine 1-phosphate receptor modulator therapy for multiple sclerosis: differential downstream receptor signalling and clinical profile effects","volume":"81","author":"Chun","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2022.10.006_bib47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pupt.2017.03.010","article-title":"FTY720 promotes pulmonary fibrosis when administered during the remodelling phase following a bleomycin-induced lung injury","volume":"44","author":"Gendron","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.apsb.2022.10.006_bib48","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI45403","article-title":"Engagement of S1P1-degradative mechanisms leads to vascular leak in mice","volume":"121","author":"Oo","year":"2011","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2022.10.006_bib49","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1074\/jbc.M610318200","article-title":"Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor","volume":"282","author":"Oo","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2022.10.006_bib50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-3-7091-1511-4_10","article-title":"Sphingolipids in lung endothelial biology and regulation of vascular integrity","author":"Abbasi","year":"2013","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.apsb.2022.10.006_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.apsb.2019.11.006","article-title":"A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models","volume":"10","author":"Jin","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.006_bib52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.exer.2004.06.018","article-title":"Thrombin-induced phosphorylation of the regulatory light chain of myosin II in cultured bovine corneal endothelial cells","volume":"79","author":"Satpathy","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.apsb.2022.10.006_bib53","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/japplphysiol.00690.2002","article-title":"S1P induces FA remodeling in human pulmonary endothelial cells: role of Rac, GIT1, FAK, and paxillin","volume":"94","author":"Shikata","year":"2003","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.apsb.2022.10.006_bib54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1113\/expphysiol.2014.082149","article-title":"Differential activation of receptors and signal pathways upon stimulation by different doses of sphingosine-1-phosphate in endothelial cells","volume":"100","author":"Li","year":"2015","journal-title":"Exp Physiol"},{"key":"10.1016\/j.apsb.2022.10.006_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107798","article-title":"Idiopathic pulmonary fibrosis: disease mechanisms and drug development","volume":"222","author":"Spagnolo","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2022.10.006_bib56","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41419-020-02747-9","article-title":"CircRNA TADA2A relieves idiopathic pulmonary fibrosis by inhibiting proliferation and activation of fibroblasts","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2022.10.006_bib57","article-title":"MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program","volume":"7","author":"Wang","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2022.10.006_bib58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.biocel.2015.06.006","article-title":"Inositol-requiring protein 1\u2013X-box-binding protein 1 pathway promotes epithelial\u2013mesenchymal transition via mediating snail expression in pulmonary fibrosis","volume":"65","author":"Mo","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.apsb.2022.10.006_bib59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cell.2019.11.027","article-title":"Progressive pulmonary fibrosis is caused by elevated mechanical tension on alveolar stem cells","volume":"180","author":"Wu","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2022.10.006_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/jcm5040045","article-title":"Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of human fibrotic diseases","volume":"5","author":"Piera-Velazquez","year":"2016","journal-title":"J Clin Med"},{"key":"10.1016\/j.apsb.2022.10.006_bib61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12931-019-1093-z","article-title":"Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-\u03b21","volume":"20","author":"Jin","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.apsb.2022.10.006_bib62","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00161-2019","article-title":"Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases","volume":"54","author":"Wollin","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.apsb.2022.10.006_bib63","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1080\/15548627.2018.1476811","article-title":"RAB26-dependent autophagy protects adherens junctional integrity in acute lung injury","volume":"14","author":"Dong","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2022.10.006_bib64","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/thorax.56.12.916","article-title":"Pulmonary 99mTc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP)","volume":"56","author":"Mogulkoc","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.apsb.2022.10.006_bib65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1165\/rcmb.2009-0408OC","article-title":"Hemorrhagic shock activates lung endothelial reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase via neutrophil NADPH oxidase","volume":"44","author":"Xiang","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.apsb.2022.10.006_bib66","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13196","article-title":"Vascular dysfunction in aged mice contributes to persistent lung fibrosis","volume":"19","author":"Caporarello","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.apsb.2022.10.006_bib67","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3892\/ol.2015.2881","article-title":"Cross-talk between endothelial and tumor cells via basic fibroblast growth factor and vascular endothelial growth factor signaling promotes lung cancer growth and angiogenesis","volume":"9","author":"Du","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.apsb.2022.10.006_bib68","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/916425","article-title":"Association of Toll-like receptor signaling and reactive oxygen species: a potential therapeutic target for posttrauma acute lung injury","volume":"2010","author":"Xiang","year":"2010","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.apsb.2022.10.006_bib69","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI76369","article-title":"Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy","volume":"125","author":"Proia","year":"2015","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2022.10.006_bib70","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI10905","article-title":"Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation","volume":"106","author":"Liu","year":"2000","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2022.10.006_bib71","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1242\/dev.078550","article-title":"S1P1 inhibits sprouting angiogenesis during vascular development","volume":"139","author":"Ben Shoham","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.apsb.2022.10.006_bib72","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87058","article-title":"HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver","volume":"1","author":"Ding","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.apsb.2022.10.006_bib73","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cell.2011.08.015","article-title":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection","volume":"146","author":"Teijaro","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2022.10.006_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201901166","article-title":"Magnesium regulates endothelial barrier functions through TRPM7, MagT1, and S1P1","volume":"6","author":"Zhu","year":"2019","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2022.10.006_bib75","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jss.2008.06.021","article-title":"Exacerbation of bleomycin-induced injury and fibrosis by pneumonectomy in the residual lung of mice","volume":"154","author":"Kakizaki","year":"2009","journal-title":"J Surg Res"},{"key":"10.1016\/j.apsb.2022.10.006_bib76","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0002-9440(10)61235-7","article-title":"Role of eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis","volume":"167","author":"Huaux","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2022.10.006_bib77","first-page":"7","article-title":"Analysis of airspace and interstitial mononuclear cell populations in human diffuse interstitial lung disease","volume":"118","author":"Davis","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.apsb.2022.10.006_bib78","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.med.55.091902.103810","article-title":"Mechanisms of pulmonary fibrosis","volume":"55","author":"Thannickal","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.apsb.2022.10.006_bib79","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.apsb.2021.06.017","article-title":"TRIB3\u2013GSK-3\u03b2 interaction promotes lung fibrosis and serves as a potential therapeutic target","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.006_bib80","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cellsig.2004.08.006","article-title":"In\u00a0vitro and in\u00a0vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights","volume":"17","author":"McVerry","year":"2005","journal-title":"Cell Signal"},{"key":"10.1016\/j.apsb.2022.10.006_bib81","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1096\/fj.03-0910fje","article-title":"The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors","volume":"18","author":"Gr\u00e4ler","year":"2004","journal-title":"Faseb J"},{"key":"10.1016\/j.apsb.2022.10.006_bib82","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.apsb.2019.11.005","article-title":"Design and synthesis of selective sphingosine-1-phosphate receptor 1 agonists with increased phosphorylation rates","volume":"10","author":"Xiao","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.006_bib83","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.devcel.2020.05.024","article-title":"Aging suppresses sphingosine-1-phosphate chaperone ApoM in circulation resulting in maladaptive organ repair","volume":"53","author":"Ding","year":"2020","journal-title":"Dev Cell"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522004233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522004233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:00:28Z","timestamp":1761930028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383522004233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2211383522004233"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2022.10.006","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2022.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}